| Future Health Pharma GmbH - Buvidal 128 mg, Depot-Injektionslösung |
| 67941 | | 07 | | Buvidal 128 mg | | Depot-Injektionslösung | | N07BC01 | | Buprenorphine | | 17.12.2020 | | |
|
| Composition |
| buprenorphinum 128 mg, N-methylpyrrolidonum, phosphatidylcholinum ex soja, glyceroli dioleas, ad solutionem pro 0.36 ml. |
| Packungsbestandteile |
| Depot-Injektionslösung | | | | | | | | Active Agent | Dose |
|---|
| Buprenorphinum | 128mg / 0.36ml |
| | BAG: Active Agent | Dose |
|---|
| Buprenorphinum | 128 mg |
| | | | Inactive agents |
|---|
| Glyceroli Dioleas | | N-Methylpyrrolidonum | | Phosphatidylcholinum ex Soja |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 014 | | 236.62 | 273.75 | A+ | SL | No |
|
